Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
100 participants
INTERVENTIONAL
2025-11-30
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sharing the Outcome of a Memory Assessment
NCT04935060
Decision Making Tool for Firearm Storage
NCT06382194
PartnerED Care: Coordinated Emergency Department Transitions for Assisted Living Patients With Alzheimer's Disease and Related Dementias
NCT06933849
Advancing Understanding of Transportation Options
NCT04141891
Improving How People Living With Dementia Are Selected for Care Coordination
NCT05651308
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Decision Aid
Participants provide feedback on the development of a decision aid for dementia therapies.
Decision aid
Patients with dementia and care partners will receive an iteration of the decision aid and provide feedback.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Decision aid
Patients with dementia and care partners will receive an iteration of the decision aid and provide feedback.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* UCHealth patient
* Ages 18 y/o and above
* Documented neurocognitive deficits suggestive of mild cognitive impairment or early dementia as determined by their treating clinician.
* English or Spanish speaking
Caregiver:
* Ages 18 y/o and above
* Identified by the study participant as the person who helps the most with their medical care outside the hospital or clinic.
* English or Spanish speaking
Clinicians:
* Neurologists, primary care clinicians, pharmacists, or psychologists involved in dementia decision-making.
* English or Spanish speaking
Exclusion Criteria
* Not English or Spanish-speaking
* Neurocognitive deficits suggestive of moderate or severe cognitive impairment or late stage dementia.
* Not able to consent for themselves
Caregiver:
* Ages 17 y/o and below
* Not English or Spanish-speaking
Clinicians:
* Neurologists, primary care clinicians, pharmacists, or psychologists involved in dementia decision-making.
* English or Spanish-speaking
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dan Matlock, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Elwyn G, Frosch D, Volandes AE, Edwards A, Montori VM. Investing in deliberation: a definition and classification of decision support interventions for people facing difficult health decisions. Med Decis Making. 2010 Nov-Dec;30(6):701-11. doi: 10.1177/0272989X10386231. Epub 2010 Nov 18.
van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T. Lecanemab in Early Alzheimer's Disease. N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIA Grant#: R21AG088955
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
24-0866
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.